Novel CBS™
Cattle Boulardii Strain
Watch this YouTube video to see how S. boulardii works:
Novel CBSTM
Cattle Boulardii Strain
Novel CBSTM is a highly concentrated and cost-effective source of the probiotic active dry yeast Saccharomyces boulardii (S. boulardii). Novel CBSTM is prepared specifically for the beef and dairy cattle industries.
Novel CBSTM is an effective probiotic because it is hardy enough to survive throughout all stages of the gastrointestinal tract (GIT) regardless of the host species. When the probiotic thrives, then the host can receive the benefits of the probiotic.
What are the benefits of Novel CBSTM?
S. boulardii is scientifically documented to have multiple health benefits: NEUTRALIZES ENDOTOXINS (Clostridium ssp., E. coli, Salmonella ssp.)
- BINDS to pathogens and REMOVES them from the host’s gut
- STIMULATES the innate and adaptive immune system of the host
- REDUCES pro-inflammatory cytokines (TNF-α, IL-6, IFN-γ)
- STRENGTHENS gut wall integrity of the host (tight junction proteins enhanced)
- INCREASES production of Short Chain Fatty Acids (Butyrate and Propionate)
There is arguably more scientific information published about the modes of action of S. boulardii than any other probiotic available because it has mostly been used in humans for the past 100 years.
In the 1980’s, S. boulardii was introduced in Europe as a feed additive for livestock, first in poultry, and then swine.
By the 1990’s, S. boulardii was being used in the North American monogastric industry. In the early 2000’s, S. boulardii was first introduced in the USA cattle industry as an effective probiotic.
Novel CBSTM has repeatable and proven efficacy not often found in most probiotics. One reason that S. boulardii provides consistent results is that it’s ideal growing temperature range matches the normal body temperature range of mammals.
S. boulardii shows 80% success rate in clinical trials
A meta-analysis of 273 randomized clinical trials for various probiotics showed that S. boulardii is in the top 3 in the number trials. The success rate of other probiotics in clinical trials is around 50% while S. boulardii has a high success rate of 80%.
A February 2024 field test on a commercial dairy in Wisconsin showed that Novel CBSTM was found above to be present and alive in the manure of lactating dairy cows at projected quantities when fed the product. This further demonstrates that Novel CBSTM thrives and survives in the GIT of bovines as it does in all mammals.